As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.

After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs, some U.S.

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.

Wilde is getting more, and better, sleep now that his sleep apnea is under control, thanks to his CPAP machine and tirzepatide. Also known as Zepbound or Mounjaro, it's the same drug helping millions ...

Despite low obesity rates, Korea sees high demand for Wegovy, prompting misuse and regulatory concerns amid societal ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...

SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, public reception, and what lies ahead for pharmacotherapy in obesity ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

Trump claimed his proposed plan to tie drug prices to those paid in foreign nations would lower by up to 90% the payments by the U.S., although experts said it’s unclear if the plan is legal ...